CALGARY, ALBERTA--(Marketwire - Jan. 8, 2008) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE:SSS) is pleased to announce that the Company’s strong intellectual property portfolio has been enhanced by the addition of a new patent granted in Australia.
